Omnicell vs NCR Voyix
OMCL and VYX side by side, both in computer and office equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How OMCL and VYX compare
Omnicell and NCR Voyix are about the same size, with market caps of $1.6B and $1.4B.
On earnings, NCR Voyix is cheaper: it trades at 15.4× trailing earnings, against 36.1× for Omnicell.
Omnicell grew revenue faster over the last twelve months (5.6% versus −8.6% for NCR Voyix).
NCR Voyix keeps more of each dollar of sales as profit, with a net margin of 4.9% compared with 3.6% at Omnicell.
Omnicell scores higher on the StockData Score (13 against 10 for NCR Voyix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | OMCL | VYX |
|---|---|---|
| Size and price | ||
| Market cap | $1.6B | $1.4B |
| Share price | $35.03 | $10.48 |
| Change, 1 year | −5.0% | −6.3% |
| Change, 5 years | −80.9% | −74.3% |
| Beta (5Y) | 0.83 | 1.26 |
| Employees | 3,580 | 14K |
| StockData Score | ||
| Total score | 13 (better) | 10 |
| Valuation score | 5 | 6 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 1 | 2 (better) |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 36.1× | 15.4× (better) |
| P/S | 1.3× | 0.6× (better) |
| P/B | 1.2× (better) | 1.5× |
| EV/EBITDA | 9.1× | 8.3× (better) |
| P/FCF | 11.0× | – |
| FCF yield | 9.1% (better) | −1.7% |
| Fair value | $54.87 | $21.12 |
| Margin of safety | 36.2% | 50.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.6% (better) | −8.6% |
| Revenue growth, 5Y average | 5.8% (better) | −15.4% |
| Net income growth (TTM) | 124% | – |
| EPS growth (TTM) | 126% | – |
| EPS growth, 5Y average | −44.2% | – |
| Profitability | ||
| Gross margin | 45.1% | – |
| Operating margin | 5.2% (better) | 2.4% |
| Net margin | 3.6% | 4.9% (better) |
| FCF margin | 11.7% (better) | −1.00% |
| Return on equity | 3.5% | 13.2% (better) |
| Return on invested capital | 4.2% (better) | 3.3% |
| Financial health | ||
| Debt / equity | 0.00 | 1.16 (better) |
| Net debt / EBITDA | – | 3.01 |
| Interest coverage | – | 0.9× |
| Current ratio | 1.66 (better) | 1.11 |
| Altman Z-score | 2.48 (better) | 1.26 |
| Piotroski F-score | 7 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | – | 2.3% |
| Shareholder yield | 0.00% | 2.3% (better) |
| Ownership | ||
| Held by institutions | 106% | 117% |
| Held by insiders | 3.3% | 0.79% |
| Insider net buying, 12 months | −$2.9M | −$105K (better) |
| Short interest, % of float | 8.6% | – |
Go deeper
- OMCL stock overview
- OMCL income statement
- OMCL valuation and score
- VYX stock overview
- VYX income statement
- VYX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.